Your browser doesn't support javascript.
loading
Survival loss linked to guideline-based indications for degenerative mitral regurgitation surgery.
Vancraeynest, David; Pouleur, Anne-Catherine; de Meester, Christophe; Pasquet, Agnès; Gerber, Bernhard; Michelena, Hector; Benfari, Giovanni; Essayagh, Benjamin; Tribouilloy, Christophe; Rusinaru, Dan; Grigioni, Francesco; Barbieri, Andrea; Bursi, Francesca; Avierinos, Jean-François; Guerra, Federico; Biagini, Elena; Keong Yeo, Khung; Hooi Ewe, See; Pui-Wai Lee, Alex; Vanoverschelde, Jean-Louis J; Enriquez-Sarano, Maurice.
Affiliation
  • Vancraeynest D; From the Department of Cardiovascular Diseases, Cliniques universitaires St. Luc, and IREC/CARD UCLouvain, Brussels, Belgium.
  • Pouleur AC; From the Department of Cardiovascular Diseases, Cliniques universitaires St. Luc, and IREC/CARD UCLouvain, Brussels, Belgium.
  • de Meester C; From the Department of Cardiovascular Diseases, Cliniques universitaires St. Luc, and IREC/CARD UCLouvain, Brussels, Belgium.
  • Pasquet A; From the Department of Cardiovascular Diseases, Cliniques universitaires St. Luc, and IREC/CARD UCLouvain, Brussels, Belgium.
  • Gerber B; From the Department of Cardiovascular Diseases, Cliniques universitaires St. Luc, and IREC/CARD UCLouvain, Brussels, Belgium.
  • Michelena H; From the Department of Cardiovascular Disease, Mayo Clinic, MN, Rochester, United States.
  • Benfari G; From the Department of Cardiovascular Disease, Mayo Clinic, MN, Rochester, United States.
  • Essayagh B; From the Department of Cardiovascular Disease, Mayo Clinic, MN, Rochester, United States.
  • Tribouilloy C; From the Department of Cardiology, University Hospital Amiens, Amiens, France, and INSERM U-1088, Jules Verne university of Picardie, Amiens, France.
  • Rusinaru D; From the Department of Cardiology, University Hospital Amiens, Amiens, France, and INSERM U-1088, Jules Verne university of Picardie, Amiens, France.
  • Grigioni F; Cardiovascular Department, University Campus Bio-Medico, Rome, Italy.
  • Barbieri A; Division of Cardiology, Department of Diagnostics, Clinical, and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Bursi F; Division of Cardiology, San Paolo Hospital, Heart and Lung Department, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy.
  • Avierinos JF; Cardiovascular Division, Aix-Marseille Université, INSERM MMG U1251, Marseille, France.
  • Guerra F; Cardiovascular Department, University Politecnica delle Marche, Ancona, Italy.
  • Biagini E; Cardiovascular Department, University Hospital S. Orsola-Malpighi, Bologna, Italy.
  • Keong Yeo K; National Heart Centre Singapore, Singapore.
  • Hooi Ewe S; National Heart Centre Singapore, Singapore.
  • Pui-Wai Lee A; Prince of Wales Hospital, Faculty of Medicine, The Chinese university of Hong Kong, People's Republic of China.
  • Vanoverschelde JJ; From the Department of Cardiovascular Diseases, Cliniques universitaires St. Luc, and IREC/CARD UCLouvain, Brussels, Belgium.
  • Enriquez-Sarano M; From the Department of Cardiovascular Disease, Mayo Clinic, MN, Rochester, United States.
Article in En | MEDLINE | ID: mdl-38996050
ABSTRACT

AIMS:

Operating on patients with severe degenerative mitral regurgitation (DMR) is based on ACC/AHA or ESC/EACTS-guidelines. Doubts persist on best surgical indications and their potential association with postoperative survival loss. We sought to investigate whether guideline-based indications lead to late postoperative survival loss in DMR-patients. METHODS AND

RESULTS:

We analyzed outcome of 2833 patients from the MIDA-registry undergoing surgical correction of DMR. Patients were stratified by surgical indications Class-I-trigger (symptoms, left ventricular end-systolic diameter≥40mm, or left ventricular ejection fraction<60%, n=1677), isolated-Class-IIa-trigger (atrial fibrillation [AF], pulmonary hypertension [PH], or left atrial diameter≥55mm, n=568), or no-trigger (n=588). Postoperative survival was compared after matching for clinical differences. Restricted-mean-survival time (RMST) was analyzed. During a median 8.5-year follow-up, 603 deaths occurred. Long-term postoperative survival was lower with Class-I-trigger than in Class-IIa-trigger and no-trigger (71.4±1.9%, 84.3±2.3%, 88.9±1.9% at 10 years, p<0.001). Having at least one Class-I-criterion led to excess mortality (p<0.001), while several Class-I-criteria conferred additional death-risk (HR1.53, 95%CI1.42-1.66). Isolated-Class-IIa-triggers conferred an excess mortality risk versus those without (HR1.46, 95%CI1.00-2.13, p=0.05). Among these patients, isolated-PH led to decreased postoperative-survival versus those without (83.7%±2.8% vs. 89.3%±1.6%, p=0.011), with the same pattern observed for AF (81.8%±5.0% vs. 88.3%±1.5%, p=0.023). According to RMST-analysis, compare to those operated on without triggers, operating on Class-I-trigger patients led to 9.4-month survival-loss (p<0.001) and operating on isolated-Class-IIa-trigger patients displayed 4.9-month survival loss (p=0.001) after 10-years.

CONCLUSIONS:

Waiting for the onset of Class-I or isolated-Class-IIa-triggers before operating on DMR patients is associated with postoperative survival loss. These data encourage an early surgical-strategy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur Heart J Cardiovasc Imaging Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur Heart J Cardiovasc Imaging Year: 2024 Document type: Article